63635-26-7Relevant articles and documents
MODIFIED PROTEINS AND PROTEIN DEGRADERS
-
Paragraph 00525; 00528; 00529, (2021/12/08)
Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.
High diastereoselectivity in the yang photocyclization via remote hydrogen abstraction reaction
Jang, Mi,Park, Bong Ser
, p. 1509 - 1514 (2016/10/09)
1-Benzoyl-1-(o-alkoxyphenyl)cyclopropanes undergo Yang photocyclization to form dihydrobenzopyranols in a stereospecific manner. The cyclopropyl group at alpha position to carbonyls gives not only a bias in the most stable geometries of the starting ketones but also conformational restriction on geometries of biradical intermediates. More importantly, intramolecular hydrogen bonds seem to give an additional effect on conformational control of the biradical reactivity.
AZOLYLMETHYLENEHYDRAZINE DERIVATIVE AND USE THEREOF
-
Page/Page column 33, (2010/04/25)
An azolylmethylidenehydrazine derivative represented by the formula (I) wherein Ar is an aryl group optionally having substituent(s), a heteroaryl group optionally having substituent(s) or a heteroaryl group optionally having substituent(s), R1
